Amin Arash, Nikdoust Farahnaz, Khorram Sepehr, Marashi Seyed Mehdi, Ghanavati Pedram, Ameri Farshid, Akbarzadeh Ashkan, Hasanvand Afshin, Khodakarim Nastaran
Department of Cardiology, School of Medicine, Shahid Madani Hospital, Lorestan University of Medical Sciences, Lorestan, Iran.
Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IR, Iran.
Mol Biol Rep. 2025 Jan 13;52(1):119. doi: 10.1007/s11033-025-10222-x.
Dengue virus (DENV) poses a considerable threat to public health on a global scale, since about two-thirds of the world's population is currently at risk of contracting this arbovirus. Being transmitted by mosquitoes, this virus is associated with a range of illnesses and a small percentage of infected individuals might suffer from severe vascular leakage. This leakage leads to hypovolemic shock syndrome, generally known as dengue shock syndrome, organ failure, and bleeding complications. The severe form of this disease is believed to be, at least partially, associated with inflammatory and thrombotic states. These issues are significantly affected by the activation of platelets and leukocytes, as well as their interactions, which may influence its prognosis. The platelets present in a thrombus are able to attract leukocytes to the site of injury. The intricate process leads to the significant accumulation, activation, and migration of leukocytes, thereby promoting thrombotic events and triggering inflammatory responses. The occurrence of these events, combined with the direct viral infection of endothelial cells, leads to vascular endothelialitis, the disruption of cellular membranes, and the subsequent release of DAMPs. As a result, considerable damage occurs in the endothelium, which activates neutrophils and platelets; thisleads to their interaction and initiates the process of Netosis. Collectively, these processes exacerbate inflammatory and thrombotic conditions. In this respect, current research has focused on understanding whether effective anti-inflammatory protocols can prevent thrombotic events or, conversely, if efficient anticoagulant regimens may lead to a reduction in cytokine storms and tissue damage. This review article aims to illuminate the platelet leukocyte crosstalk, detailing the mechanisms through which platelets may play a role in the pathogenesis of DENV. The research outputs are particularly important in severe cases, in which case their interactions with leukocytes can exacerbate both inflammation and thrombosis in a mutually reinforcing manner.
登革病毒(DENV)在全球范围内对公共卫生构成了相当大的威胁,因为目前世界上约三分之二的人口有感染这种虫媒病毒的风险。这种病毒通过蚊子传播,与一系列疾病相关,一小部分感染者可能会出现严重的血管渗漏。这种渗漏会导致低血容量性休克综合征,通常称为登革休克综合征、器官衰竭和出血并发症。这种疾病的严重形式被认为至少部分与炎症和血栓形成状态有关。这些问题受到血小板和白细胞的激活及其相互作用的显著影响,这可能会影响其预后。血栓中的血小板能够将白细胞吸引到损伤部位。这个复杂的过程导致白细胞大量聚集、激活和迁移,从而促进血栓形成事件并引发炎症反应。这些事件的发生,加上内皮细胞的直接病毒感染,导致血管内皮炎、细胞膜破坏以及随后的损伤相关分子模式(DAMPs)释放。结果,内皮细胞发生相当大的损伤,激活中性粒细胞和血小板;这导致它们相互作用并启动NETosis过程。总的来说,这些过程加剧了炎症和血栓形成状况。在这方面,目前的研究集中在了解有效的抗炎方案是否可以预防血栓形成事件,或者相反,有效的抗凝方案是否可能导致细胞因子风暴和组织损伤的减少。这篇综述文章旨在阐明血小板与白细胞的相互作用,详细说明血小板在登革病毒发病机制中可能发挥作用的机制。这些研究结果在严重病例中尤为重要,在严重病例中,它们与白细胞的相互作用会以相互促进的方式加剧炎症和血栓形成。